{"transactions":[{"id":670798,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":17828,"kind":"person","name":"Xu Cong Claire","position":1,"cik":"0002114309","reported_name":"Xu Cong Claire","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Clinical Development"}}],"security":"Restricted Share Units","published_at":"2026-09-01T22:00:08.000Z","date":"2026-08-30","kind":"exercise","planned":false,"acquired":false,"shares":4079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."},{"field":"shares","element":"transactionShares","label":"F8","text":"Reported securities represent ADSs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"On May 30, 2024, the Reporting Person was granted 65,270 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting ratably over the subsequent 12 quarters on the 30th day of each third month."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"On May 30, 2024, the Reporting Person was granted 65,270 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting ratably over the subsequent 12 quarters on the 30th day of each third month."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"Reported securities represent ADSs."}],"balance_after":28558,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4079},"source":{"system":"sec-edgar","filing":"0002114309-26-000007","document":"form4-09012026_060901.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000211430926000007/form4-09012026_060901.xml","form_type":"4"}},{"id":670797,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":17828,"kind":"person","name":"Xu Cong Claire","position":1,"cik":"0002114309","reported_name":"Xu Cong Claire","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Clinical Development"}}],"security":"Ordinary Shares","published_at":"2026-09-01T22:00:08.000Z","date":"2026-08-31","kind":"sale","planned":false,"acquired":false,"shares":3282,"price":0.79,"value":2592.78,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F5","text":"Reported securities are represented by 1,427 ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reported sales price represents the converted sales price of the ADSs of $1.8186."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Reported securities are represented by 132,261 ADSs."}],"balance_after":304201,"source":{"system":"sec-edgar","filing":"0002114309-26-000007","document":"form4-09012026_060901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000211430926000007/form4-09012026_060901.xml","form_type":"4"}},{"id":670796,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":17828,"kind":"person","name":"Xu Cong Claire","position":1,"cik":"0002114309","reported_name":"Xu Cong Claire","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Clinical Development"}}],"security":"Ordinary Shares","published_at":"2026-09-01T22:00:08.000Z","date":"2026-08-30","kind":"exercise","planned":false,"acquired":true,"shares":9382,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reported securities are represented by 4,079 ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reported securities are represented by 133,688 ADSs."}],"balance_after":307483,"source":{"system":"sec-edgar","filing":"0002114309-26-000007","document":"form4-09012026_060901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000211430926000007/form4-09012026_060901.xml","form_type":"4"}},{"id":713337,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":17828,"kind":"person","name":"Xu Cong Claire","position":1,"cik":"0002114309","reported_name":"Xu Cong Claire","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Development"}}],"security":"Restricted Share Units","published_at":"2026-07-07T23:50:18.000Z","date":"2026-07-04","kind":"exercise","planned":false,"acquired":false,"shares":5405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."},{"field":"shares","element":"transactionShares","label":"F8","text":"Reported securities represent ADSs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Fully vested."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"Reported securities represent ADSs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Reported securities represent ADSs."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5405},"source":{"system":"sec-edgar","filing":"0002114309-26-000005","document":"form4-07072026_110715.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000211430926000005/form4-07072026_110715.xml","form_type":"4"}},{"id":713336,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":17828,"kind":"person","name":"Xu Cong Claire","position":1,"cik":"0002114309","reported_name":"Xu Cong Claire","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Development"}}],"security":"Ordinary Shares","published_at":"2026-07-07T23:50:18.000Z","date":"2026-07-06","kind":"sale","planned":false,"acquired":false,"shares":4485,"price":0.89,"value":3991.65,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F5","text":"Reported securities are represented by 1,950 ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reported sales price represents the converted sales price of the ADSs of $2.04."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Reported securities are represented by 129,609 ADSs."}],"balance_after":298101,"source":{"system":"sec-edgar","filing":"0002114309-26-000005","document":"form4-07072026_110715.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000211430926000005/form4-07072026_110715.xml","form_type":"4"}},{"id":713335,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":17828,"kind":"person","name":"Xu Cong Claire","position":1,"cik":"0002114309","reported_name":"Xu Cong Claire","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Development"}}],"security":"Ordinary Shares","published_at":"2026-07-07T23:50:18.000Z","date":"2026-07-04","kind":"exercise","planned":false,"acquired":true,"shares":12432,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reported securities are represented by 5,405 ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reported securities are represented by 131,559 ADSs."}],"balance_after":302586,"source":{"system":"sec-edgar","filing":"0002114309-26-000005","document":"form4-07072026_110715.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000211430926000005/form4-07072026_110715.xml","form_type":"4"}},{"id":753951,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":17828,"kind":"person","name":"Xu Cong Claire","position":1,"cik":"0002114309","reported_name":"Xu Cong Claire","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Development"}}],"security":"Restricted Share Units","published_at":"2026-06-02T22:46:59.000Z","date":"2026-05-30","kind":"exercise","planned":false,"acquired":false,"shares":4079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."},{"field":"shares","element":"transactionShares","label":"F8","text":"Reported securities represent ADSs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"On May 30, 2024, the Reporting Person was granted 65,270 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting ratably over the subsequent 12 quarters on the 30th day of each third month."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"On May 30, 2024, the Reporting Person was granted 65,270 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting ratably over the subsequent 12 quarters on the 30th day of each third month."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F8","text":"Reported securities represent ADSs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Reported securities represent ADSs."}],"balance_after":32637,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4079},"source":{"system":"sec-edgar","filing":"0002114309-26-000003","document":"form4-06022026_100655.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000211430926000003/form4-06022026_100655.xml","form_type":"4"}},{"id":753950,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":17828,"kind":"person","name":"Xu Cong Claire","position":1,"cik":"0002114309","reported_name":"Xu Cong Claire","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Development"}}],"security":"Ordinary Shares","published_at":"2026-06-02T22:46:59.000Z","date":"2026-06-01","kind":"sale","planned":false,"acquired":false,"shares":3494,"price":3.94,"value":13766.36,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F5","text":"Reported securities are represented by 1,519 ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reported sales price represents the converted sales price of the ADSs of $1.71."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Reported securities are represented by 126,154 ADSs."}],"balance_after":290154,"source":{"system":"sec-edgar","filing":"0002114309-26-000003","document":"form4-06022026_100655.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000211430926000003/form4-06022026_100655.xml","form_type":"4"}},{"id":753949,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":17828,"kind":"person","name":"Xu Cong Claire","position":1,"cik":"0002114309","reported_name":"Xu Cong Claire","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Development"}}],"security":"Ordinary Shares","published_at":"2026-06-02T22:46:59.000Z","date":"2026-05-30","kind":"exercise","planned":false,"acquired":true,"shares":9382,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reported securities are represented by 4,079 ADSs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reported securities are represented by 127,673 ADSs."}],"balance_after":293648,"source":{"system":"sec-edgar","filing":"0002114309-26-000003","document":"form4-06022026_100655.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000211430926000003/form4-06022026_100655.xml","form_type":"4"}}]}